Does INCLISIRAN Cause Injection site swelling? 55 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Injection site swelling have been filed in association with INCLISIRAN (LEQVIO). This represents 0.9% of all adverse event reports for INCLISIRAN.
55
Reports of Injection site swelling with INCLISIRAN
0.9%
of all INCLISIRAN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Injection site swelling From INCLISIRAN?
Of the 55 reports, 2 (3.6%) required hospitalization.
Is Injection site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INCLISIRAN. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does INCLISIRAN Cause?
Arthralgia (689)
Myalgia (518)
Injection site pain (488)
Low density lipoprotein increased (423)
Pain in extremity (417)
Pain (342)
Fatigue (325)
Drug ineffective (318)
Diarrhoea (309)
Dyspnoea (297)
What Other Drugs Cause Injection site swelling?
ETANERCEPT (9,992)
DUPILUMAB (9,582)
ADALIMUMAB (4,428)
EVOLOCUMAB (1,933)
GLATIRAMER (1,836)
IXEKIZUMAB (1,615)
TIRZEPATIDE (1,131)
ENBREL (1,121)
HYDROXYPROGESTERONE CAPROATE (924)
HUMIRA (838)
Which INCLISIRAN Alternatives Have Lower Injection site swelling Risk?
INCLISIRAN vs INCOBOTULINUMTOXINA
INCLISIRAN vs INDACATEROL
INCLISIRAN vs INDAPAMIDE
INCLISIRAN vs INDAPAMIDE\PERINDOPRIL
INCLISIRAN vs INDAPAMIDE\PERINDOPRIL ARGININE